已收盤 09-20 16:00:00 美东时间
-0.160
-8.21%
Iveda Solutions (NASDAQ:IVDA) said it has approved a 1-for-8 reverse stock split of its common stock. The common stock is expected to start trading on a split-adjusted basis on September 17. More on I...
09-13 20:03
Iveda Solutions (NASDAQ:IVDA) on Thursday said it has entered into definitive agreements for the sale and issuance of 5M shares of common stock of the company at an offering price of $0.43 per share, ...
09-05 22:53
Shares of companies within the broader tech sector are trading lower amid conce...
08-05 23:34
根据披露的机构调研信息,7月19日,九泰基金对上市公司迈威生物进行了调研。 从市场表现来看,迈威生物近一周股价下跌8.06%,近一个月下跌17.69%。 基金市...
07-22 19:00
转自:九洲药业 •TIVDAK是第一个在既往接受过治疗的复发性或转移性宫颈癌患者中获得积极总体生存数据的抗体偶联药物(ADC) •从加速批准转为完全批准时基于全...
05-21 18:45
Iveda Solutions(IVDA.US):2024年Q1财报实现营收34.677万美元,前值为220.5万美元;每股收益为-0.07美元,前值为-0....
05-21 06:31
腾讯自选股精选每日热门大公司动态,点击上方可一键收听↑ 1、问界回应M7运城事故:电池未起火 信号切断导致车门无法自动解锁 2、比亚迪仰望4月销售952辆,仰望...
05-06 19:44
大公司: 天猫618取消官方预售,将在5月20日直接开卖 36氪获悉,今年天猫618已于今日起接受报名。相比往年,今年618最大的变化在于取消官方预售环节,5月...
05-06 18:20
Genmab (Otc) (GMAB) has released an update. Genmab’s TIVDAK has received full F...
04-30 19:28